Rhenman & Partners Asset Management AB

13F Portfolio Filings

Most recent 13F
Q4 2023
Location
Stockholm, Sweden
CIK
0001599882
All SEC filings
View on sec.gov
Holdings Value
Quarter Holdings Value ($000) Top Holdings Form Type Date Filed Filing ID
Q4 2023 85 1,001,010 MDT, LLY, BSX, VRTX 13F-HR 2/13/2024 000121390024012894
Q3 2023 85 927,505 LLY, BSX, BMRN, REGN RESTATEMENT 11/13/2023 000121390023085459
Q2 2023 83 948,682 LLY, BMRN, CI, BSX 13F-HR 8/11/2023 000121390023065840
Q1 2023 88 910,885 LILLY ELI & CO, UNH, BSX, REGN 13F-HR 5/11/2023 000121390023038637
Q4 2022 93 958,473 LLY, ABC, MDT, BSX 13F-HR 2/13/2023 000121390023010457
Q3 2022 90 955,010 LLY, UNH, BSX, VRTX 13F-HR 11/14/2022 000121390022072302
Q2 2022 86 880,150 CI, LLY, ABBV, UNH 13F-HR 8/12/2022 000121390022047070
Q1 2022 89 1,013,563 LLY, HZNP, ABBV, UNH 13F-HR 5/13/2022 000121390022026487
Q4 2021 92 1,503,868 UNH, PFE, LLY, HZNP 13F-HR 2/11/2022 000121390022006636
Q3 2021 92 1,424,766 HZNP, UNH, ELV, JNJ 13F-HR 11/12/2021 000121390021058306
Q2 2021 94 1,473,245 UNH, HZNP, VRTX, JAZZ 13F-HR 8/13/2021 000121390021042239
Q1 2021 92 1,434,218 HZNP, JNJ, UNH, JAZZ 13F-HR 5/14/2021 000121390021026215
Q4 2020 83 1,225,693 ABBV, BMRN, HZNP, MDT 13F-HR 1/19/2021 000121390021002698
Q3 2020 82 1,124,651 BMRN, HZNP, NVCR, UNH 13F-HR 10/13/2020 000121390020031038
Q2 2020 94 925,638 HZNP, VRTX, UNH, ABBV 13F-HR 7/16/2020 000121390020017623
Q1 2020 85 713,821 HZNP, VRTX, ABBV, NVCR 13F-HR 4/16/2020 000121390020009314
Q4 2019 94 912,515 ESPR, VRTX, NVCR, HZNP 13F-HR 1/17/2020 000121390020001297
Q3 2019 93 797,699 VRTX, HZNP, NVCR, ALXN 13F-HR 10/16/2019 000121390019020405
Q2 2019 88 907,850 VRTX, HUM, JAZZ, ALXN 13F-HR 7/22/2019 000121390019013307
Q1 2019 93 854,928 UNH, JAZZ, VRTX, ABMD 13F-HR 4/11/2019 000121390019006146
Q4 2018 89 874,811 UNH, CI, MDT, CVS 13F-HR 2/5/2019 000121390019001686
Q3 2018 88 997,986 CI, CVS, ALXN, VRTX 13F-HR 10/3/2018 000141588918001462
Q2 2018 89 977,105 NKTR, Horizon Pharma Plc, VRTX, INCY 13F-HR 7/20/2018 000141588918001149
Q1 2018 92 811,255 Horizon Pharma Plc, CELG, ALXN, VRTX 13F-HR 4/11/2018 000141588918000595
Q4 2017 95 740,066 Horizon Pharma Plc, ESPR, ADMS, EXEL 13F-HR 1/19/2018 000141588918000085
Q3 2017 94 783,338 Horizon Pharma Plc, VRTX, EXEL, ABMD 13F-HR 10/13/2017 000141588917001660
Q2 2017 108 696,477 Horizon Pharma Plc, EXEL, NVCR, ALXN 13F-HR 7/11/2017 000141588917001145
Q1 2017 104 631,470 Horizon Pharma Plc, ESPR, BIIB, GKOS 13F-HR 4/19/2017 000141588917000651
Q4 2016 108 521,630 GILD, BMY, AGN, LLY 13F-HR 1/13/2017 000141588917000078
Q3 2016 107 629,612 SHPG, LLY, ALXN, CELG 13F-HR 11/8/2016 000141588916007347
Q2 2016 97 563,148 ALXN, GILD, CELG, BIIB 13F-HR 8/1/2016 000141588916006640
Q1 2016 92 503,761 ALXN, GILD, BMRN, PFE 13F-HR 4/19/2016 000141588916005562
Q4 2015 96 661,398 PRGO, ABMD, MDT, ALXN 13F-HR 1/19/2016 000141588916004481
Q3 2015 91 627,273 AMGN, ALXN, MDT, UNH 13F-HR 10/26/2015 000141588915003497
Q2 2015 96 832,686 iShares Tr Nasdaq Biotech ETF puts, Select Sector SPDR Tr SBI Healthcare puts, UNH, ALXN 13F-HR 7/30/2015 000141588915002492
Q1 2015 89 593,072 SELECT SECTOR SPDR TR puts, ALXN, CELG, MRK 13F-HR 5/13/2015 000141588915001643
Q4 2014 84 345,008 CELG, GILD, CVS, REGN 13F-HR 2/9/2015 000141588915000450
Q3 2014 100 341,532 Johnson & Johnson calls, ALKS, UHS, ALXN 13F-HR 11/3/2014 000141588914003285
Q2 2014 96 337,007 BIIB, COV, GILD, ALXN 13F-HR 7/31/2014 000141588914002277
Q1 2014 91 333,168 GILD, ALXN, REGN, BIIB 13F-HR 5/14/2014 000152153614000049
Q4 2013 84 255,659 REGN, CELG, GILD, CVS 13F-HR 2/14/2014 000152153614000045
Additional filings from Rhenman & Partners Asset Management AB that have since been restated